GeoVax Labs, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, the company offers GEO-MVA-MUC1, a vaccine candidate, which is in preclinical trial for the treatment of solid tumor cancers; GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-EMO1-Z, which is in preclinical trial for the treatment of Ebola Zaire; GEO-EMO1-S, which is in preclinical trial for the treatment of Ebola Sudan; GEO-MM01 treatment for marburg; and GEO-MVA for the treatment of Mpox and small pox. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; and the U.S. Department of Defense. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia.
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-05-14 | -0.84 | -2.62 | -210.06% |
| 2026-03-23 | -5.35 | — | — |
| 2025-11-13 | -6.62 | -7.75 | -16.98% |
| 2025-07-28 | -9.00 | -8.75 | +2.78% |
| 2025-05-01 | -16.44 | -11.25 | +31.56% |
| 2025-03-27 | -19.20 | -7.50 | +60.94% |
| 2024-11-12 | -32.90 | -22.75 | +30.85% |
| 2024-08-06 | -84.12 | -49.75 | +40.86% |
| 2024-05-14 | -139.00 | -61.75 | +55.58% |
| 2024-02-29 | -105.00 | -98.50 | +6.19% |
| 2023-11-08 | -90.00 | -120.00 | -33.33% |
| 2023-08-09 | -63.75 | -82.50 | -29.41% |
| 2023-05-04 | -84.37 | -56.25 | +33.33% |
| 2023-03-23 | -75.00 | -75.00 | — |
| 2022-11-09 | -45.00 | -63.75 | -41.67% |
| 2022-08-03 | -112.50 | -67.50 | +40.00% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| GOVX | +78.35% | +29.56% | -51.81% | -91.92% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +75.39% | +34.20% | -48.37% | -104.61% |